Trizivir Oral Tablet 300-150-300Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Trizivir: Oral tablet (300-150-300mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_13369.JPG
Trizivir Tab
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: GX LL1 
Drug Image file DrugItem_3332.JPG
Trizivir Tab
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: GX LL1 
Drug Image file DrugItem_3332.JPG
Trizivir Tab
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: GX LL1 

What is this Medicine?

ABACAVIR; LAMIVUDINE, 3TC; ZIDOVUDINE, ZDV (a ba KA vir; la MI vyoo deen; zye DOE vyoo deen) is three antiretroviral medicines in one tablet. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

CVS Pharmacy Patient Statistics for Trizivir: Oral tablet(300-150-300mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Trizivir 300mg-150mg-300mg Tablet

NDC: 497020217
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Trizivir 300mg-150mg-300mg Tablet
Drug Image file DrugItem_13369.JPG
ViiV Healthcare a GSK and Pfizer Company
Pill Identification: GX LL1 
Shape: oblong
Color: blue-green

Reported Side Effects for Trizivir 300mg-150mg-300mg Tablet

Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Type Of Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Removal Of Spleen Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Wheezing Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Heart Muscle Disease Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Increased Blood Sugar Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
6.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
10.0-19.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
13.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Trizivir 300mg-150mg-300mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Trizivir 300mg-150mg-300mg Tablet(Abacavir Sulfate)
Alcohol and Abacavir Sulfate(Abacavir Sulfate)
Side effects from Abacavir such as nausea/vomiting, tiredness, loss of appetite, headache, or inability to sleep (insomnia) or other sleep disorders may get worse if you drink alcohol-containing drinks. Avoid alcohol-containing drinks while taking abacavir.
Moderate Lifestyle Interaction
Marijuana and Trizivir 300mg-150mg-300mg Tablet(Abacavir Sulfate)
Marijuana and Nucleoside reverse transcriptase inhibitors(Abacavir Sulfate)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral nucleoside reverse transcriptase inhibitors (NRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Trizivir

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5